Neogen (NEOG) Free Cash Flow Growth (3y) (2013 - 2026)
Analysis
Neogen (NEOG) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 35.65% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 60.39% |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -26.31% |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 14.27% |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | -28.98% |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -18.45% |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | -19.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -26.31% |
| Feb 28, 2026 | 32.83% |
| Nov 30, 2025 | 31.08% |
| Aug 31, 2025 | 21.46% |
| May 31, 2025 | -66.32% |
| Feb 28, 2025 | -491.46% |
| Nov 30, 2024 | 18.42% |
| Aug 31, 2024 | -65.96% |
| May 31, 2024 | -44.17% |
| Feb 29, 2024 | -175.52% |
| Nov 30, 2023 | -36.79% |
| Aug 31, 2023 | -33.23% |
| May 31, 2023 | 54.07% |
| Feb 28, 2023 | -58.49% |
| Nov 30, 2022 | -70.54% |
| Aug 31, 2022 | -52.88% |
| May 31, 2022 | -24.29% |
| Feb 28, 2022 | -26.25% |
| Nov 30, 2021 | 5.93% |
| Aug 31, 2021 | 15.66% |